Blood Pressure, Capilar Glucose and Anthropometric Measures in a Yanomámi Population. Cad. Saúde Públ., Rio de Janeiro, 9 (4): 428-438, oct/dec, 1993. Seventy-two Yanomámi Indians from Surucucus, Roraima, Brazil, were examined

SUMMARYThe objectives of this study were to determine both the prevalence of microsporidial intestinal infection and the clinical outcome of the disease in a cohort of 40 HIV-infected patients presenting with chronic diarrhea in Rio de Janeiro, Brazil. Each patient, after clinical evaluation, had stools and intestinal fragments examined for viral, bacterial and parasitic pathogens. Microsporidia were found in 11 patients (27.5%) either in stools or in duodenal or ileal biopsies. Microsporidial spores were found more frequently in stools than in biopsy fragments. Samples examined using transmission electron microscopy (n=3) or polymerase chain reaction (n=6) confirmed Enterocytozoon bieneusi as the causative agent. Microsporidia were the only potential enteric pathogens found in 5 of the 11 patients. Other pathogens were also detected in the intestinal tract of 21 patients, but diarrhea remained unexplained in 8. We concluded that microsporidial infection is frequently found in HIV infected persons in Rio de Janeiro, and it seems to be a marker of advanced stage of AIDS.

Confl itos de interesse: não há

RESUMO O ensaio analisa a dinâmica de atuação corporativa da medicina brasileira na pandemia de Covid-19, de março de 2020 a julho de 2021, a partir de documentos e material institucional das entidades médicas nacionais, de organizações estudantis e de coletivos de médicos de expressão nacional, além de matérias jornalísticas e publicações da literatura científica sobre o tema. O período é marcado pela politização da agenda corporativa e pelo alinhamento com os discursos negacionistas do governo de Jair Bolsonaro. Argumenta-se que esse processo é resultado de uma politização anterior: o embate contra o Programa Mais Médicos no período de 2013, ano de seu lançamento, a 2019, quando foi encerrado pelo governo. Os dois momentos históricos revelam um duplo negacionismo da corporação médica – acentuando fragilidades, contradições e dilemas da encruzilhada da profissão – que exigirá diálogos internos e com a sociedade, para novos consensos da identidade corporativa e do projeto profissional da medicina. A compreensão dos entrelaçamentos, disputas e sentidos das dinâmicas e rumos da atuação corporativa da medicina permitem identificar problemas estruturais de raízes políticas que impedem maiores avanços na consolidação do Sistema Único de Saúde.

This essay analyzes the dynamics of Brazilian medical practice’s corporate action in the COVID-19 pandemic, from March 2020 to July 2021, from documents and institutional material of national medical entities, student organizations, groups of nationally reputed physicians, and journalistic articles and scientific literature publications on the subject. This period is marked by the politicization of the corporate agenda and the alignment with the denialist discourses of Jair Bolsonaro’s administration. It is argued that this process stems from a previous politicization: the clash against the More Doctors Program from 2013, the year of its launch, to 2019, when the Government deactivated it. The two historical moments reveal the dual denialism of the medical corporation, emphasizing weaknesses, contradictions, and dilemmas of the profession’s crossroads, which will require internal and social dialogues for a new consensus on corporate identity and the professional project of Medicine. Understanding the intertwining, disputes, and meanings of the dynamics and directions of the corporate action of Medicine allows identifying structural problems of political roots that prevent further advances in the consolidation of the Unified Health System.

No abstract